HomeCompareHOLX vs EPD

HOLX vs EPD: Dividend Comparison 2026

HOLX yields 2.65% · EPD yields 5.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPD wins by $36.4K in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
EPD
EPD
● Live price
5.57%
Share price
$39.08
Annual div
$2.18
5Y div CAGR
21.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.1K
Annual income
$9,876.61
Full EPD calculator →

Portfolio growth — HOLX vs EPD

📍 EPD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXEPD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + EPD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
EPD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
EPD
Annual income on $10K today (after 15% tax)
$473.07/yr
After 10yr DRIP, annual income (after tax)
$8,395.12/yr
At 15% tax rate, EPD beats the other by $8,128.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + EPD for your $10,000?

HOLX: 50%EPD: 50%
100% EPD50/50100% HOLX
Portfolio after 10yr
$41.9K
Annual income
$5,095.32/yr
Blended yield
12.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPD right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
EPD
Analyst Ratings
35
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$35.86
-8.2% upside vs current
Range: $32.00 — $40.00
Altman Z
2.1
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
EPD buys
0
No recent congressional trades found for HOLX or EPD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXEPD
Forward yield2.65%5.57%
Annual dividend / share$2.00$2.18
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%21.4%
Portfolio after 10y$23.6K$60.1K
Annual income after 10y$314.03$9,876.61
Total dividends collected$2.9K$34.2K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$77.80$35.86

Year-by-year: HOLX vs EPD ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrEPD PortfolioEPD Income/yrGap
1← crossover$10,965$264.73$11,376$675.65$411.00EPD
2$12,004$271.27$13,044$872.04$1.0KEPD
3$13,121$277.55$15,092$1,134.50$2.0KEPD
4$14,323$283.54$17,637$1,489.23$3.3KEPD
5$15,615$289.27$20,846$1,974.66$5.2KEPD
6$17,003$294.73$24,954$2,648.08$8.0KEPD
7$18,493$299.93$30,297$3,596.41$11.8KEPD
8$20,093$304.87$37,372$4,954.13$17.3KEPD
9$21,809$309.57$46,921$6,933.42$25.1KEPD
10$23,649$314.03$60,082$9,876.61$36.4KEPD

HOLX vs EPD: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

EPDEnergy

Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through four segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services. It operates 19 natural gas processing facilities located in Colorado, Louisiana, Mississippi, New Mexico, Texas, and Wyoming; NGL pipelines; NGL fractionation facilities; NGL and related product storage facilities; and NGL marine terminals. The Crude Oil Pipelines & Services segment operates crude oil pipelines; and crude oil storage and marine terminals, which include a fleet of 255 tractor-trailer tank trucks that are used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates natural gas pipeline systems to gather, treat, and transport natural gas. It leases underground salt dome natural gas storage facilities in Napoleonville, Louisiana; owns an underground salt dome storage cavern in Wharton County, Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related marketing activities; butane isomerization complex and related deisobutanizer operations; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines and terminals; and ethylene export terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is headquartered in Houston, Texas.

Full EPD Calculator →
📬

Get this HOLX vs EPD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.